-
Je něco špatně v tomto záznamu ?
In-vitro drug release testing of parenteral formulations via an agarose gel envelope to closer mimic tissue firmness
J. Kožák, M. Rabišková, A. Lamprecht
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
Odkazy
PubMed
33326826
DOI
10.1016/j.ijpharm.2020.120142
Knihovny.cz E-zdroje
- MeSH
- kopolymer kyseliny glykolové a mléčné MeSH
- kyselina mléčná * MeSH
- kyselina polyglykolová * MeSH
- mikrosféry MeSH
- sefarosa MeSH
- uvolňování léčiv MeSH
- velikost částic MeSH
- Publikační typ
- časopisecké články MeSH
Current in vitro drug-release testing of the sustained-release parenterals represents the in vivo situation insufficiently. In this work, a thin agarose hydrogel layer surrounding the tested dosage form was proposed to mimic the tissue. The method was applied on implantable formulations of different geometries (films, microspheres, and cylindrical implants); prepared from various polymers (several Resomer® grades or ethyl cellulose) and loaded with different model drugs: flurbiprofen, lidocaine or risperidone. The hydrogel layer did not possess any retarding effect on the released drug and acted as a physical restriction to swelling and/or plastic deformation of the tested dosage forms. This led to a different surface area available for drug-release compared with testing in release medium alone and correspondingly to significantly different release profiles of the majority of the formulations obtained between the two methods (e.g. t50% = 18 days in pure release medium vs. t50% = 26 days in gel-setup for risperidone loaded Resomer® 503 H films or t50% = 7 days vs. t50% = 19 days for risperidone loaded Resomer® 503 H microspheres). The limited space for swelling and the rigidity of the agarose gel might mimic the tight encapsulation of the dosage form in the tissue better than the conventional liquid medium.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019336
- 003
- CZ-PrNML
- 005
- 20210830100917.0
- 007
- ta
- 008
- 210728s2021 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2020.120142 $2 doi
- 035 __
- $a (PubMed)33326826
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Kožák, Jan $u Department of Pharmaceutics, Institute of Pharmacy, University of Bonn, Gerhard-Domagk-Straße 3, 53121 Bonn, Germany; Department of Pharmaceutical Technology, Faculty of Pharmacy, Charles University, Akademika Heyrovskeho 1203/8, 500 05 Hradec Kralove, Czech Republic
- 245 10
- $a In-vitro drug release testing of parenteral formulations via an agarose gel envelope to closer mimic tissue firmness / $c J. Kožák, M. Rabišková, A. Lamprecht
- 520 9_
- $a Current in vitro drug-release testing of the sustained-release parenterals represents the in vivo situation insufficiently. In this work, a thin agarose hydrogel layer surrounding the tested dosage form was proposed to mimic the tissue. The method was applied on implantable formulations of different geometries (films, microspheres, and cylindrical implants); prepared from various polymers (several Resomer® grades or ethyl cellulose) and loaded with different model drugs: flurbiprofen, lidocaine or risperidone. The hydrogel layer did not possess any retarding effect on the released drug and acted as a physical restriction to swelling and/or plastic deformation of the tested dosage forms. This led to a different surface area available for drug-release compared with testing in release medium alone and correspondingly to significantly different release profiles of the majority of the formulations obtained between the two methods (e.g. t50% = 18 days in pure release medium vs. t50% = 26 days in gel-setup for risperidone loaded Resomer® 503 H films or t50% = 7 days vs. t50% = 19 days for risperidone loaded Resomer® 503 H microspheres). The limited space for swelling and the rigidity of the agarose gel might mimic the tight encapsulation of the dosage form in the tissue better than the conventional liquid medium.
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 12
- $a kyselina mléčná $7 D019344
- 650 _2
- $a mikrosféry $7 D008863
- 650 _2
- $a velikost částic $7 D010316
- 650 12
- $a kyselina polyglykolová $7 D011100
- 650 _2
- $a kopolymer kyseliny glykolové a mléčné $7 D000077182
- 650 _2
- $a sefarosa $7 D012685
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Rabišková, Miloslava $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Charles University, Akademika Heyrovskeho 1203/8, 500 05 Hradec Kralove, Czech Republic
- 700 1_
- $a Lamprecht, Alf $u Department of Pharmaceutics, Institute of Pharmacy, University of Bonn, Gerhard-Domagk-Straße 3, 53121 Bonn, Germany. Electronic address: alf.lamprecht@uni-bonn.de
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 594, č. - (2021), s. 120142
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33326826 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830100918 $b ABA008
- 999 __
- $a ok $b bmc $g 1690214 $s 1139782
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 594 $c - $d 120142 $e 20201214 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
- LZP __
- $a Pubmed-20210728